Theravance Biopharma
TBPH
TBPH
84 hedge funds and large institutions have $1.31B invested in Theravance Biopharma in 2017 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 30 increasing their positions, 25 reducing their positions, and 11 closing their positions.
Holders
84
Holders Change
–
Holders Change %
0%
% of All Funds
1.91%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
11
Increased
30
Reduced
25
Closed
11
Calls
$2K
Puts
$944K
Net Calls
-$942K
Net Calls Change
+$851K
Top Buyers
Top Sellers
1 |
OM
1
Opaleye Management
Boston,
Massachusetts
|
$0 |
2 |
2
First Manhattan
New York
|
$40.6M |
3 |
3
Balyasny Asset Management
Chicago,
Illinois
|
$2.47M |
4 |
4
BlackRock
New York
|
$104M |
5 |
5
Goldman Sachs
New York
|
$5.51M |